Insight

In May 2024, the decades-long debate between the FDA and CLIA program over regulation of LDTs, seemingly came to an end with the publication of an FDA final rule, making it explicit that IVDs are classified as devices under the FD&C Act, including when the...

Private payers are having to think outside the box to prioritize cost-savings for laboratory services, especially with the